关注
Łukasz Szukalski
Łukasz Szukalski
在 cm.umk.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
A multicenter retrospective study of 223 patients with t (14; 16) in multiple myeloma
S Goldman‐Mazur, A Jurczyszyn, JJ Castillo, A Waszczuk‐Gajda, ...
American journal of hematology 95 (5), 503-509, 2020
462020
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS …
D Dytfeld, T Wróbel, K Jamroziak, T Kubicki, P Robak, A Walter-Croneck, ...
The Lancet Oncology 24 (2), 139-150, 2023
362023
Endothelial activation and stress index (EASIX) as an early Predictor for mortality and overall survival in hematological and non-hematological patients with COVID-19 …
E Kalicińska, M Biernat, J Rybka, A Zińczuk, J Janocha-Litwin, ...
Journal of Clinical Medicine 10 (19), 4373, 2021
192021
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study
MM Pérez Encinas, M Sobas, MT Gómez‐Casares, A Abuin Blanco, ...
European Journal of Haematology 106 (3), 371-379, 2021
172021
Outcome of SARS-CoV-2-infected Polish patients with chronic lymphocytic leukemia
B Puła, K Pruszczyk, E Pietrusza, M Morawska, W Piszczek, E Kalicińska, ...
Cancers 14 (3), 558, 2022
132022
Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
E Kalicińska, B Kuszczak, J Dębski, Ł Szukalski, M Wątek, J Strzała, ...
Supportive Care in Cancer 29, 323-330, 2021
122021
Diagnostic and prognostic power of active DNA demethylation pathway intermediates in acute myelogenous leukemia and myelodysplastic syndromes
A Skalska-Bugala, M Starczak, Ł Szukalski, M Gawronski, ...
Cells 11 (5), 888, 2022
72022
Mean platelet volume has prognostic value in chronic lymphocytic leukemia
M Masternak, B Puła, J Knap, A Waszczuk-Gajda, J Drozd-Sokołowska, ...
Cancer Management and Research, 9977-9985, 2020
72020
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients
S Goldman-Mazur, A Jurczyszyn, JJ Castillo, A Waszczuk-Gajda, ...
Leukemia & Lymphoma 61 (8), 1885-1893, 2020
72020
Cutaneous manifestation of chronic lymphocytic leukemia: a case report and a literature review
Ł Szukalski, M Sysakiewicz-Buda, K Męcińska-Jundziłł, A Białecka, ...
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2019
62019
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study
R Stuckey, JC Ianotto, M Santoro, A Czyż, MM Perez Encinas, ...
British Journal of Haematology 199 (1), 86-94, 2022
52022
The prognostic impact of t (14; 16) in multiple myeloma: a multicenter retrospective study of 213 patients. Is it time to revise the revised ISS?
A Jurczyszyn, S Goldman-Mazur, JJ Castillo, A Waszczuk-Gajda, ...
Blood 132, 4452, 2018
52018
Prediction of major bleeding events in 1381 patients with essential thrombocythemia
R Stuckey, JC Ianotto, M Santoro, A Czyż, MMP Encinas, ...
International Journal of Hematology 118 (5), 589-595, 2023
42023
Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: a Polish experience
J Czyż, Ł Szukalski, A Szukalska, BK Budziszewska, E Lech-Marańda, ...
Advances in Clinical and Experimental Medicine 31 (6), 707-710, 2022
32022
Mass Spectrometry-Based Assessment of M protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma
T Kubicki, D Dytfeld, D Barnidge, D Sakrikar, A Przybyłowicz-Chalecka, ...
Blood, 2024
22024
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either …
T Kubicki, D Dytfeld, T Wróbel, K Jamroziak, P Robak, J Czyż, ...
British Journal of Haematology 203 (5), 792-802, 2023
22023
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors
B Puła, M Długosz-Danecka, A Salomon-Perzyński, A Szymczyk, ...
Advances in Medical Sciences 65 (2), 371-377, 2020
22020
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and …
T Kubicki, K Jamroziak, P Robak, J Czyż, A Tyczyńska, A Druzd-Sitek, ...
Polish archives of internal medicine 134 (5), 16749, 2024
12024
Hematological Malignancies in the Polish Population: What are the Predictors of Outcome in Patients Admitted to Intensive Care Unit?
E Kalicińska, B Kuszczak, J Dębski, Ł Szukalski, J Czyż, M Wątek, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S219, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–19